Tag: AFT Pharmaceuticals
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
AHMADA welcomes release of new pain relief medication
The Australian Health Manufacturers and Development Association (AHMADA) welcomed the launch of the new medication, MAXIGESIC®, which reduces pain and inflammation.
According to the media...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
